At Medical Developments International (MDI) our aim is to provide unique and innovative products to assist our customers in the management of acute and procedural pain, delivery of asthma medications, resuscitation and oxygen therapies for human and veterinary patients.
Our products are used in a number of countries with the list of new country registrations growing rapidly. With widely recognised brands such as Penthrox, Space Chamber, OXI-Port, OXI-Sok and OXI-Life, Medical Developments International manufactures products that are the first choice of professionals in the pre-hospital and first aid environments, and university, research, hospital and veterinary institutions.
Headquartered in Melbourne, Australia, MDI develops, manufactures and markets its range of products worldwide. From its state of the art factory in Melbourne, MDI supplies the global needs for methoxyflurane in analgesia.